Targeting loss of heterozygosity for cancer-specific immunotherapy.
Proc Natl Acad Sci U S A
; 118(12)2021 03 23.
Article
in En
| MEDLINE
| ID: mdl-33731480
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Loss of Heterozygosity
/
Molecular Targeted Therapy
/
Immunotherapy
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2021
Document type:
Article
Country of publication:
United States